These programs provide a comprehensive approach to early detection and disease prevention. Patients are screened or tested using comprehensive whole-person data to identify their risk and potential need for enhanced screening or proactive care.

Prevention4ME Program: This comprehensive risk assessment is integrated into routine medical care to help us use genetics to identify potential hereditary cancer risks, and recommend proactive, personalized protocols. Learn more.

MCED (Multi-cancer Early Detection) Testing Program: For patients with a high lifetime risk of cancer, the use of multi-cancer early detection testing can help detect cancer signals across more than 50 types of cancer using innovative technology through a single blood test. Learn more

Geno4ME Program: We use Whole Genome Sequencing (WGS) testing to empower patients with their genetic information and to identify their risk for certain inherited diseases and pharmacogenomics, while enabling genomic research at the population health level. Read about our findings: Providence Genomics Releases Preliminary Geno4ME Study Findings.